Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 11 studies | 24% ± 11% | |
ciliated cell | 11 studies | 44% ± 15% | |
smooth muscle cell | 9 studies | 25% ± 9% | |
pericyte | 8 studies | 23% ± 5% | |
fibroblast | 8 studies | 25% ± 13% | |
type I pneumocyte | 7 studies | 43% ± 8% | |
type II pneumocyte | 6 studies | 74% ± 14% | |
epithelial cell | 6 studies | 28% ± 14% | |
astrocyte | 4 studies | 17% ± 1% | |
neuron | 4 studies | 31% ± 23% | |
endothelial cell of artery | 4 studies | 20% ± 3% | |
endothelial cell of vascular tree | 4 studies | 18% ± 1% | |
glomerular endothelial cell | 3 studies | 17% ± 1% | |
kidney loop of Henle epithelial cell | 3 studies | 24% ± 1% | |
myofibroblast cell | 3 studies | 27% ± 4% | |
vein endothelial cell | 3 studies | 17% ± 1% | |
retinal ganglion cell | 3 studies | 55% ± 32% | |
adventitial cell | 3 studies | 22% ± 1% | |
connective tissue cell | 3 studies | 27% ± 8% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 5320.42 | 2638 / 2642 | 100% | 14.80 | 705 / 705 |
thymus | 100% | 3737.33 | 652 / 653 | 99% | 24.02 | 599 / 605 |
uterus | 100% | 2598.19 | 170 / 170 | 97% | 10.64 | 447 / 459 |
adrenal gland | 100% | 3181.81 | 258 / 258 | 96% | 10.65 | 221 / 230 |
breast | 99% | 2306.95 | 456 / 459 | 96% | 6.80 | 1077 / 1118 |
lung | 100% | 5071.80 | 577 / 578 | 95% | 8.90 | 1102 / 1155 |
esophagus | 99% | 2808.10 | 1428 / 1445 | 95% | 5.67 | 173 / 183 |
liver | 95% | 2099.70 | 215 / 226 | 95% | 6.30 | 386 / 406 |
intestine | 96% | 3196.41 | 927 / 966 | 94% | 7.63 | 494 / 527 |
ovary | 100% | 4310.52 | 180 / 180 | 87% | 4.70 | 376 / 430 |
stomach | 94% | 1998.54 | 337 / 359 | 93% | 6.40 | 267 / 286 |
skin | 90% | 1616.50 | 1635 / 1809 | 97% | 6.25 | 457 / 472 |
kidney | 98% | 2321.20 | 87 / 89 | 84% | 4.53 | 756 / 901 |
prostate | 95% | 1951.00 | 233 / 245 | 81% | 3.10 | 405 / 502 |
bladder | 90% | 2314.95 | 19 / 21 | 82% | 5.56 | 412 / 504 |
pancreas | 35% | 424.09 | 115 / 328 | 97% | 8.83 | 172 / 178 |
adipose | 100% | 3025.42 | 1204 / 1204 | 0% | 0 | 0 / 0 |
muscle | 100% | 21676.65 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 3901.34 | 241 / 241 | 0% | 0 | 0 / 0 |
heart | 99% | 13790.53 | 856 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 3710.21 | 1327 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 6.30 | 79 / 80 |
tonsil | 0% | 0 | 0 / 0 | 98% | 7.05 | 44 / 45 |
lymph node | 0% | 0 | 0 / 0 | 69% | 4.27 | 20 / 29 |
peripheral blood | 52% | 931.00 | 480 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0046940 | Biological process | nucleoside monophosphate phosphorylation |
GO_0009142 | Biological process | nucleoside triphosphate biosynthetic process |
GO_0046033 | Biological process | AMP metabolic process |
GO_0006172 | Biological process | ADP biosynthetic process |
GO_0046034 | Biological process | ATP metabolic process |
GO_0015949 | Biological process | nucleobase-containing small molecule interconversion |
GO_0001520 | Cellular component | outer dense fiber |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0004017 | Molecular function | adenylate kinase activity |
GO_0004550 | Molecular function | nucleoside diphosphate kinase activity |
GO_0046899 | Molecular function | nucleoside triphosphate adenylate kinase activity |
GO_0005524 | Molecular function | ATP binding |
Gene name | AK1 |
Protein name | Adenylate kinase isoenzyme 1 (AK 1) (EC 2.7.4.3) (EC 2.7.4.6) (ATP-AMP transphosphorylase 1) (ATP:AMP phosphotransferase) (Adenylate monophosphate kinase) (Myokinase) Adenylate kinase isoenzyme 1 (AK 1) (EC 2.7.4.10) (EC 2.7.4.3) (EC 2.7.4.6) (ATP-AMP transphosphorylase 1) (ATP:AMP phosphotransferase) (Adenylate monophosphate kinase) (Myokinase) Adenylate kinase 1 |
Synonyms | HTL-S-58j hCG_2039407 |
Description | FUNCTION: Catalyzes the reversible transfer of the terminal phosphate group between ATP and AMP . Exhibits nucleoside diphosphate kinase activity, catalyzing the production of ATP, CTP, GTP, UTP, dATP, dCTP, dGTP and dTTP from the corresponding diphosphate substrates with either ATP or GTP as phosphate donor . Also catalyzes at a very low rate the synthesis of thiamine triphosphate (ThTP) from thiamine diphosphate (ThDP) and ADP (By similarity). . FUNCTION: Catalyzes the reversible transfer of the terminal phosphate group between ATP and AMP. Also displays broad nucleoside diphosphate kinase activity. Plays an important role in cellular energy homeostasis and in adenine nucleotide metabolism. . FUNCTION: Catalyzes the reversible transfer of the terminal phosphate group between ATP and AMP. Also displays broad nucleoside diphosphate kinase activity. Plays an important role in cellular energy homeostasis and in adenine nucleotide metabolism. . |
Accessions | ENST00000550992.1 ENST00000373156.5 ENST00000550143.5 ENST00000644144.2 Q6FGX9 ENST00000223836.10 P00568 F8VRY5 H0YID2 Q5T9B7 |